Ferritin, Lipid Peroxidation and Redox-Cycling Xenobiotics

References

• Aust S. D., Morehouse L. A., Thomas C. E. Role of metals in oxygen radical reactions. Journal of Free Radicals in Biology and Medicine. 1985; 1: 3–25
   PubMedGoogle Scholar
• Halliwell B., Gutteridge J. M. C. The importance of free radicals and catalytic metal ions in human diseases. Molecular Aspecis of Medicine. 1985; 8: 89–193
   PubMed Web of Science ®Google Scholar
• Girotti A. W. Mechanisms of lipid peroxidation. Journal of Free Rodicals in Biology and Medicine. 1985; 1: 81–95
   Google Scholar
• Ursini F., Maiorino M., Hochstein P., Ernster L. Microsomal lipid peroxidation: mechanisms of initiation. Journal of Free Radicals in Biology and Medicine 1989; 6: 31–36
   Google Scholar
• Minottiand G., Aust S. D. The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. Journal of Biological Chemistry. 1987; 262: 1098–1104
   PubMedGoogle Scholar
• Biemond P., Swaak A. J. G., Van Eijk H. G., Koster J. F. Superoxide dependent iron release from ferritin in inflammatory diseases. Journal of Free Radicals in Biology and Medicine. 1988; 4: 185–198
   Google Scholar
• Funk F., Lenders J., Crichton R. R., Schneider W. Reductive mobilisation of ferritin iron. European Journal of Biochmistry. 1985; 152: 167–172
   PubMedGoogle Scholar
• Monteiro H. P., Winterbourn C. C. Release of iron from ferritin by divicine. isouramil, acid-hydrolysed vicine and dialuric acid, and initiation oflipid peroxidation. Archives of Biochemistry and Biophysics. 1989; 271: 536–545
   PubMedGoogle Scholar
• Monteiro H. P., Winterbourn C. C. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochemical Pharmacology. 1989, (in press).
   PubMedGoogle Scholar
• Winterbourn C. C., Cowden W. B., Sutton H. C. Auto-oxidation of dialuric acid, divicine and isouramil. Superoxide dependent and independent mechanisms. Biochemical Pharmacology. 1989; 38: 611–618
   PubMed Web of Science ®Google Scholar
• Winterbourn C. C. Inhibition of autoxidation of divicine and isouramil by the combination of superoxide dismutase and reduced glutathione. Archives of Biochemistry and Biophysics. 1989; 271: 447–455
   PubMed Web of Science ®Google Scholar
• Winterbourn C. C., Munday R. Glutathione-mediated redox cycling of alloxan: mechanisms of superoxide dismutase inhibition and of metalcatalysed OH formation. Biochemical Pharmacology 1989; 38: 271–277
   PubMed Web of Science ®Google Scholar
• Thomas C. E., Aust S. D. Rat liver microsomal NADPH-dependent release of iron from ferritin and lipid peroxidation. Journal of Free Radicals in Biology and Medicine. 1985; 1: 293–300
   PubMedGoogle Scholar
• Thomas C. E., Aust S. D. Release of iron from ferritin by cardiotoxic anthracycline antibiotics. Archives of Biochmistry and Biophysics. 1986; 248: 684–689
   PubMed Web of Science ®Google Scholar
• Monteiro H. P., Vile G. F., Winterbourn C. C. Release of iron from ferritin by semiquinone. anthracycline. bipyridyl and nitroaromatic radicals. Journal of Free Radicals in Biology and Medicine. 1989; 6: 587–591
   Google Scholar
• Watt G. D., Frankel R. B., Papaefthymiou G. C. Reduction of mammalian ferritin. Proceedings of the Nurional Academy of Science USA 1985; 82: 3640–3643
   PubMed Web of Science ®Google Scholar
• Hochstein P., Nordenbrand K., Ernster L. Evidence for the involvement of iron in the ADP-activated peroxidation of lipids in microsomes and mitochondria. Biochemical and Biophysical Research Communications. 1964; 14: 323–328
   PubMed Web of Science ®Google Scholar
• Morehouse L. A., Thomas C. E., Aust S. D. Superoxide generation by NADPH-cytochrome P450 reductax: the effect of iron chelators and the role of superoxide in microsornal lipid peroxidation. Archives of Biochemistry and Biophysics. 1984; 232: 366–377
   PubMed Web of Science ®Google Scholar
• Mimnaugh E. G., Gram T. E., Trush M. A. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and erect of reactive oxygen scavengers. Jourtial of Pharmacology and Experimental Therapeutics 1983; 226: 806–816
   PubMed Web of Science ®Google Scholar
• Vile G. F., Winterbourn C. C. Adriamycin-dependent peroxidation of rat liver and heart microsomes catalysed by iron chelates and ferritin: maximum peroxidation at low oxygen partial pressures. Biochemical Pharmacolog 1988; 37: 2893–2897
   PubMedGoogle Scholar
• Winston G. W., Feierman D. E., Cederbaum A. I. The role of iron chclates in hydroxyl radical production by rat liver microsomcs, NADPH-cytochromc P-450 rcductase and xanthine oxidase. Archives of Biochemistry and Biophysics. 1984; 232: 378–390
   PubMed Web of Science ®Google Scholar
• Vile G. F., Winterbourn C. C. Microsomal reduction of low molecular weight Fe3+chelates and ferritin: enhancement by adriamycin, paraquat, menadione and anthraquinone-2-sulphonatc and inhibition by oxygen. Archives of Biochemistry and Biophysics. 1988; 267: 606–613
   PubMed Web of Science ®Google Scholar
• Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochemical and Biophysical Research Communications 1977; 77: 797–803
   PubMed Web of Science ®Google Scholar
• Green M. D., Speyer J. L., Stecy P., Rey M., Kremer E., Sanger J., Feit F., Blum R. H., Wernz J. C., Ward C., London C., Dubin N., Muggia F. M. ICRF-187 (ICRF) prevents doxorubicin (DOX) cardiotoxicity (CTOX): Results of a randomized clinical trial. Proceedings of the American Sociery of Clinical Oncology. 1987; 6, Abs. A104.
   Google Scholar
• Belt R. J. Prevention of adriamycin-induced cardiotoxicity by ICRF-187 (NSC-169780). Proceedings of the American Society of Clinical Oncology. 1984; 3, Abs. C10S.
   Google Scholar
• Dawson K. M. Studies on the stability and cellular distribution of dioxopiperazines in cultured BHK-2lS cells. Biochemical Pharmacology 1975; 24: 2249–2253
   PubMed Web of Science ®Google Scholar